Patient-Derived Tumor Organoids

A personalized testing service using patient-derived organoids to evaluate drug efficacy and identify optimal therapeutic candidates for individual cancer treatment protocols.

Three-dimensional organoid culture development from patient tumor samples for personalized drug testing. This approach preserves tumor heterogeneity and enables functional assessment of therapeutic responses.

A research service leveraging organoid technology as a powerful diagnostic tool and research platform due to its fast growth cycle, ease of experimental operation, and convenient high-throughput screening capabilities. Organoids are three-dimensional in vitro cultured tissue analogues formed from adult stem cells or pluripotent stem cells, featuring high morphological and genetic similarity to corresponding human organ tissues and the ability to recapitulate organ physiological functions.

A research service platform leveraging organoid technology with advantages of rapid growth cycles, easy experimental operation, and convenient high-throughput screening. Organoids serve as powerful diagnostic tools and research platforms for clinical and scientific applications in cancer research.

Personalized precision medicine service for malignant tumors using organoid technology. Enables accurate diagnosis and treatment planning through patient-derived tumor models. Supports clinical decision-making for oncology patients.

Scientific research service providing tumor organoid development and analysis for research institutions and clinical centers. Supports preclinical and translational oncology research. Facilitates drug efficacy testing and personalized treatment validation.

Development of patient-derived xenograft models in laboratory animals for in vivo drug efficacy evaluation. This service enables comprehensive preclinical assessment of anticancer therapeutics in physiologically relevant tumor environments.

Patient-derived cell model development service for preclinical drug evaluation and tumor biology studies. This service provides authentic cellular models that retain primary tumor characteristics for improved drug testing accuracy.

A clinical service that provides personalized treatment planning using patient-derived 3D cell culture models. The service leverages cultured patient cells to enable precision medicine approaches in cancer care. It supports clinicians in making informed treatment decisions based on individual patient cell behavior.

Precision tumor medication technology service providing engineered cancer kinase-targeted cell libraries and primary cancer cell biobanks for preclinical drug development and tumor precision treatment. Supports oncology research through standardized cell models and bioanalytical services.

Custom 3D-printed anatomical models created from patient imaging data for preoperative planning and surgical training. Enables surgeons to practice complex procedures and improve surgical outcomes through detailed anatomical visualization.

True-to-life organ models designed for surgical training that deliver unmatched surgical feel and accuracy. These high-fidelity hydrogel organs replace the need for cadavers or animals in surgical education and provide realistic, reusable training solutions.